Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
The FDA has announced that McNeil Consumer Healthcare, a unit of Johnson & Johnson, has voluntarily recalled certain infant and children’s liquid medicines because of manufacturing deficiencies. The announcement comes only two weeks after we told you about possible toxins found in Johnson & Johnson baby shampoo.
According an FDA statement, consumers are advised to stop using certain infants’ and children’s Tylenol, Motrin, Zyrtec and Benadryl products because they may contain higher concentrations of an active ingredient than specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. Both the FDA and McNeil insist the potential for serious risk is remote, but have advised consumers to stop using the products because these deficiencies may affect the potency, purity or quality of the products.
For a complete list recalled products, you can check out the recall notice here. No class action lawsuit has been filed yet, but if history is any indicator, we’re bound to see one pop up in the next few weeks. We’ll keep you posted if a class action suit is filed.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
One thought on Children’s Tylenol, Motrin and Other Products Recalled
add me